University of Wisconsin Madison, Department of Medical Physics, Madison, Wisconsin, United States.
QUEL Imaging, White River Junction, Vermont, United States.
J Biomed Opt. 2023 Sep;28(9):096007. doi: 10.1117/1.JBO.28.9.096007. Epub 2023 Sep 21.
Fluorescence guided surgery (FGS) has demonstrated improvements in decision making and patient outcomes for a wide range of surgical procedures. Not only can FGS systems provide a higher level of structural perfusion accuracy in tissue reconstruction cases but they can also serve for real-time functional characterization. Multiple FGS devices have been Food and Drug administration (FDA) cleared for use in open and laparoscopic surgery. Despite the rapid growth of the field, there has been a lack standardization methods.
This work overviews commonalities inherent to optical imaging methods that can be exploited to produce such a standardization procedure. Furthermore, a system evaluation pipeline is proposed and executed through the use of photo-stable indocyanine green fluorescence phantoms. Five different FDA-approved open-field FGS systems are used and evaluated with the proposed method.
The proposed pipeline encompasses the following characterization: (1) imaging spatial resolution and sharpness, (2) sensitivity and linearity, (3) imaging depth into tissue, (4) imaging system DOF, (5) uniformity of illumination, (6) spatial distortion, (7) signal to background ratio, (8) excitation bands, and (9) illumination wavelength and power.
The results highlight how such a standardization approach can be successfully implemented for inter-system comparisons as well as how to better understand essential features within each FGS setup.
Despite clinical use being the end goal, a robust yet simple standardization pipeline before clinical trials, such as the one presented herein, should benefit regulatory agencies, manufacturers, and end-users to better assess basic performance and improvements to be made in next generation FGS systems.
荧光引导手术(FGS)已经证明,在广泛的手术过程中,它可以改善决策制定和患者的预后。FGS 系统不仅可以在组织重建病例中提供更高水平的结构灌注准确性,还可以实时进行功能特征描述。多种 FGS 设备已经获得美国食品和药物管理局(FDA)的批准,可用于开放和腹腔镜手术。尽管该领域发展迅速,但缺乏标准化方法。
本文概述了光学成像方法所固有的共性,这些共性可以被利用来产生这样的标准化程序。此外,提出并执行了一个系统评估流程,该流程通过使用光稳定的吲哚菁绿荧光体模来实现。使用提出的方法评估了五种不同的经 FDA 批准的开放式 FGS 系统。
所提出的流水线包括以下特征描述:(1)成像空间分辨率和锐度,(2)灵敏度和线性度,(3)组织内成像深度,(4)成像系统景深,(5)照明均匀性,(6)空间失真,(7)信号与背景比,(8)激发带,(9)照明波长和功率。
结果突出了这种标准化方法如何成功地用于系统间比较,以及如何更好地理解每个 FGS 设置中的基本特征。
尽管临床应用是最终目标,但在临床试验之前,如本文所述,建立一个稳健而简单的标准化流程,应该使监管机构、制造商和最终用户受益,以更好地评估基本性能,并改进下一代 FGS 系统。